Kathryn A. Whitehead

Lipid-like materials for low-dose, in vivo gene silencing

Kevin T. Love, Kerry P. Mahon, Christopher G. Levins et al. · Proceedings of the National Academy of Sciences · 2010 · 965 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

Kathryn A. Whitehead, J. Robert Dorkin, Arturo J. Vegas et al. · Nature Communications · 2014 · 617 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation

Delai Chen, Kevin T. Love, Yi Chen et al. · Journal of the American Chemical Society · 2012 · 418 citations

Pharmacy, Biotechnology, Pharmaceutics +17

Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization

Rebecca L. Ball, Palak Bajaj, Kathryn A. Whitehead · International Journal of Nanomedicine · 2016 · 320 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA

Rebecca L. Ball, Khalid A. Hajj, Jamie Vizelman et al. · Nano Letters · 2018 · 307 citations

Pharmacy, Pharmaceutics, Pharmacology +17